Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,069.50    -6.00 (-0.56%)
Bid:
1,072.50
Ask:
1,073.00
Spread: 0.50 (0.047%)
Market Cap: £3.84b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

BURBERRY FINAL TERMS MEDIUM-TERM BOND

13 Jun 2024 17:24

RNS Number : 3920S
Burberry Group PLC
13 June 2024
 

BURBERRY GROUP PLC

 

BURBERRY ANNOUNCES FINAL TERMS OF MEDIUM-TERM BOND

 

 

 

Burberry Group plc ('Burberry' or the 'Company') is pleased to announce that it has completed the pricing of a £300,000,000 5.75% bond due 20 June 2030.

 

The proceeds of the Bond will be used for general corporate purposes.

 

The Bond is expected to be rated Baa2 by Moody's Investor Services.

 

13 June 2024

 

Equity Investors and analysts

Lauren Wu Leng

Head of Investor Relations

020 3425 2007

lauren.wuleng@burberry.com

Debt investors

Max Izzard

SVP, Group and Corporate Finance

07808 098803

Max.Izzard@burberry.com

Fiona Rose

Group Treasurer

020 3367 4270

Fiona.Rose@burberry.com

Media

Andrew Roberts

SVP, Corporate Relations and Engagement

020 3367 3764

Andrew.Roberts@burberry.com

 

Relevant stabilisation regulations including FCA/ICMA will apply. Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in the EEA or the UK.

 

This announcement is directed only at (i) persons who are outside the United Kingdom (the "UK"), or (ii) persons who are in the UK who are (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (b) otherwise, persons to whom this announcement may lawfully be communicated pursuant to the Order (all such persons together being referred to as "relevant persons"). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

The notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act).

 

A rating is not a recommendation to buy, sell or hold the notes and may be subject to suspension, reduction or withdrawal at any time.

 

This announcement is not intended to be distributed to or reviewed by anyone other than you. This announcement does not constitute an offer to sell or a solicitation of an offer to buy securities.

 

This announcement does not constitute nor form a part of any offer or solicitation to purchase or subscribe for securities in Singapore or elsewhere. The notes referred to herein have not been and will not be offered or sold or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to any person in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 (Chapter 289) of Singapore, as modified or amended from time to time (the "SFA")) pursuant to Section 274 of the SFA or (ii) to an accredited investor (as defined in Section 4A of the SFA) pursuant to and in accordance with the conditions specified in Section 275 of the SFA.

 

Notification under Section 309B of the SFA - Solely for the purposes of its obligations pursuant to Sections 309B(1)(a) and 309B(1)(c) of the SFA and the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore (the "CMP Regulations 2018"), the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of the SFA), the classification of the notes as prescribed capital markets products (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).

 

Notes to editors

 

· Founded in 1856, Burberry is a global luxury brand, headquartered in London.

· Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. Its ADR symbol is OTC:BURBY.

· BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODQXLFFZQLLBBF
Date   Source Headline
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company
18th Jul 20257:00 amRNSFirst Quarter Trading Update
16th Jul 20252:15 pmRNSResult of AGM
3rd Jul 20255:36 pmRNSHolding(s) in Company
1st Jul 202511:17 amRNSHolding(s) in Company
1st Jul 202510:56 amRNSTotal Voting Rights
27th Jun 20251:00 pmRNSDirector/PDMR Shareholding
4th Jun 20255:27 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSTotal Voting Rights
29th May 202512:47 pmRNSAnnual Financial Report
14th May 20257:00 amRNSBurberry FY25 Preliminary Results
2nd May 20253:28 pmRNSDirectorate Change
1st May 202511:26 amRNSTotal Voting Rights
1st Apr 20253:58 pmRNSHolding(s) in Company
1st Apr 20252:37 pmRNSTotal Voting Rights
3rd Mar 20252:26 pmRNSBlock listing Interim Review
3rd Mar 20252:20 pmRNSTotal Voting Rights
3rd Feb 202510:28 amRNSTotal Voting Rights
24th Jan 20257:00 amRNSThird Quarter Trading Update
16th Jan 20254:25 pmRNS2024 Annual General Meeting Voting Outcome Update
2nd Jan 202510:41 amRNSTotal Voting Rights
20th Dec 20243:33 pmRNSDirector/PDMR Shareholding
18th Dec 20244:00 pmRNSBoard Changes
12th Dec 20245:40 pmRNSDirector/PDMR Shareholding
3rd Dec 20241:58 pmRNSPublication of a Prospectus
2nd Dec 202411:31 amRNSTotal Voting Rights
14th Nov 20247:00 amRNSBurberry Interim Results
1st Nov 202411:59 amRNSTotal Voting Rights
1st Oct 20241:01 pmRNSTotal Voting Rights
19th Sep 20246:18 pmRNSHolding(s) in Company - Correction
2nd Sep 20246:03 pmRNSBlock listing Interim Review
2nd Sep 20245:36 pmRNSHolding(s) in Company
2nd Sep 202412:23 pmRNSTotal Voting Rights
15th Aug 20244:35 pmRNSTotal Voting Rights
6th Aug 202412:28 pmRNSDirector Declaration
5th Aug 20246:27 pmRNSDirector/PDMR Shareholding - Correction
5th Aug 20245:54 pmRNSDirector/PDMR Shareholding
1st Aug 202410:17 amRNSTotal Voting Rights
31st Jul 202410:25 amRNSDirector/PDMR Shareholding
30th Jul 20246:04 pmRNSDirector/PDMR Shareholding
18th Jul 20242:45 pmRNSDirector/PDMR Shareholding
17th Jul 20243:53 pmRNSDirector/PDMR Shareholding
16th Jul 20245:02 pmRNSResult of AGM
16th Jul 20244:52 pmRNSDirector/PDMR Shareholding
16th Jul 20249:36 amRNSDirector/PDMR Shareholding
16th Jul 20249:34 amRNSDirector/PDMR Shareholding
16th Jul 20249:17 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.